Device Trial Radar · NCT01686841
A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production
Last checked: Nov 20, 2026Latest source record: Sep 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11
Actual
Start
Aug 16, 2012
Primary completion
Apr 29, 2013
Study completion Dec 31, 2013
Sponsor
- Lead sponsor
- Zeltiq AestheticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 18, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years, up to 25 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the safety and feasibility of reducing human sebum production using the ZELTIQ System.
Conditions
- Acne
Interventions
The Zeltiq SystemDevice
Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Sebum Production in Treated Sites as Compared to Baseline Using Sebutape Measurements.Time frame: Baseline and 2 weeks post-treatment
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Massachusetts General Hospital
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.